Gli altri portali
Notizie
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II…
Leuven, BELGIË – 28 oktober 2026 – 18u00 CET Oxurion NV (Euronext Brussel: OXUR), een bedrijf met hoofdkantoor in Leuven, België, heeft vandaag aangekondigd dat het, in overeenstemming met de Belgische transparantiewetgeving1, de volgende transparantiekennisgevingen heeft ontvangen: Oxurion ontving een transparantiekennisgeving op 27 oktober 2026…
Actusnews Wire
28/10/2026
Oxurion Receives Transparency Notifications from Atlas Special Opportunities II…
Leuven, BELGIUM – October 28, 2026 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received transparency notifications as follows: Oxurion received a transparency notification on October 27, 2026, from Atlas Special Opportunities II…
Actusnews Wire
28/10/2026
DMS GROUP : CONTRACT FOR THE DELIVERY OF 15 !M1 MOBILE X-RAY UNITS TO THE…
Equipments to be delivered by the end of 2026 €1.5 million contract, to be invoiced in Q4 27 October 2026 – 7:30 am – Diagnostic Medical Systems Group (Euronext Growth Paris: FR0012202497 - ALDMS), a specialist in high-performance medical imaging systems for digital radiology and bone densitometry, announces, in partnership with Santax Medico, its…
Actusnews Wire
27/10/2026
Lumibird: Photonics continues its strong growth with a +13.5% increase in…
Lannion, 26 October 2026 – 5:45 pm PHOTONICS CONTINUES ITS STRONG GROWTH WITH A +13.5% INCREASE IN REVENUE OVER THE FIRST 9 MONTHS OF 2026 Consolidated revenue rose by +8.8% over the first 9 months and +12.0% in the 3rd quarter The LUMIBIRD Group (FR0000038242 – LBIRD), the European leader in laser technologies, reported consolidated revenue of…
Actusnews Wire
26/10/2026
THX Pharma Reports Its Cash Position as of September 30, 2026
Lyon, France – October 22, 2026 – 6:00 p.m. CEST – THX Pharma (Theranexus), an innovative biopharmaceutical company developing treatments for rare neurological diseases, today announced its cash position as of September 30, 2026. As of September 30, 2026, cash and cash equivalents amounted to €16.0 million, compared with €17…
Actusnews Wire
22/10/2026
BASTIDE : 2025-2026 annual results
7.9% organic growth Recurring operating margin of 9.2%, above target Strong increase in net profit Group share to €58.1 million Operating free cash flow up €16 million to €38 million Free cash flow of €148 million €135 million reduction in net debt and leverage ratio lowered to 2.37x 2026-2027 outlook Revenue exceeding €500 million with a stable…
Actusnews Wire
21/10/2026
DMS GROUP : Q3 2026 REVENUE: EUR 7.9 MILLION
Significant decline in Radiology revenue, continuing to be affected by the challenging economic environment in Europe and the conflict in the Middle East Continued strong growth in Bone Densitometry Early signs of a recovery in commercial activity since mid-September, particularly in Europe and the Middle East Reaffirmed target to improve…
Actusnews Wire
19/10/2026
Oxurion Receives Transparency Notifications from Atlas Special Opportunities II…
Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC Leuven, BELGIUM – October 14, 2026 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received transparency notifications as follows: Oxurion received a…
Actusnews Wire
15/10/2026
Oxurion ontvangt transparantiekennisgevingen van Market Wizards B.V. en van…
Leuven, BELGIË – 14 oktober 2026 – 18u00 CET Oxurion NV (Euronext Brussel: OXUR), een bedrijf met hoofdkantoor in Leuven, België, heeft vandaag aangekondigd dat het, in overeenstemming met de Belgische transparantiewetgeving1, de volgende transparantiekennisgevingen heeft ontvangen: Oxurion ontving een transparantiekennisgeving op 13 oktober 2026…
Actusnews Wire
15/10/2026
Oxurion Receives Transparency Notifications from Market Wizards B.V. and Atlas…
Leuven, BELGIUM – October 12, 2026 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received transparency notifications as follows: Oxurion received a transparency notification on October 9, 2026, from Market Wizards B.V…
Actusnews Wire
12/10/2026
Oxurion ontvangt transparantiekennisgevingen van Market Wizards B.V. en van…
Leuven, BELGIË – 12 oktober 2026 – 18u00 CET Oxurion NV (Euronext Brussel: OXUR), een bedrijf met hoofdkantoor in Leuven, België, heeft vandaag aangekondigd dat het, in overeenstemming met de Belgische transparantiewetgeving1, de volgende transparantiekennisgevingen heeft ontvangen: Oxurion ontving een transparantiekennisgeving op 9 oktober 2026 van Market Wizards B…
Actusnews Wire
12/10/2026
Oxurion ontvangt transparantiekennisgeving van Market Wizards B.V.
Leuven, BELGIË – 9 oktober 2026 – 18u00 CET Oxurion NV (Euronext Brussel: OXUR), een bedrijf met hoofdkantoor in Leuven, België, heeft vandaag aangekondigd dat het, in overeenstemming met de Belgische transparantiewetgeving1, de volgende transparantiekennisgeving heeft ontvangen: Oxurion ontving een transparantiekennisgeving op 8 oktober 2026 van Market Wizards B…
Actusnews Wire
09/10/2026
Oxurion Receives Transparency Notification from Market Wizards B.V.
Leuven, BELGIUM – October 9, 2026 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received transparency notification as follows: Oxurion received a transparency notification on October 8, 2026, from Market Wizards B.V…
Actusnews Wire
09/10/2026
OXURION : Information on the Total Number of Voting Rights (Denominator)…
Atlas Special Opportunities, LLC has converted 2 convertible bonds in Oxurion resulting in a EUR 50,000 capital increase. This is part of Atlas Special Opportunities, LLC's EUR 20 million Capital Commitment[1]. Leuven, BELGIUM – October 8, 2026 – 06:00 PM CET – In accordance with article 15 of the Belgian Act of May 2, 2007 on the disclosure of…
Actusnews Wire
08/10/2026
OXURION : Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer)…
Atlas Special Opportunities, LLC heeft 2 converteerbare obligaties in Oxurion geconverteerd resulterende in een kapitaalverhoging van EUR 50.000. Deze conversie vormt deel van Atlas Special Opportunities, LLC's EUR 20 miljoen kapitaaltoezegging1. Leuven, BELGIUM– 8 oktober 2026 – 18u00 CET – Overeenkomstig artikel 15 van de Wet van 2 mei 2007 op de…
Actusnews Wire
08/10/2026
Klea Holding confirms its gradual rebound in Q3 2026 and targets revenue growth…
Paris, 8 October 2026 KLEA HOLDING (FR0013481835 – ALKLH), a group whose ambition is to capitalise on the strong economic development of the Middle East to maximise the growth and value creation of its businesses, announces its unaudited revenue for the third quarter of 2026. The third quarter confirms the rebound that began in the spring at its…
Actusnews Wire
08/10/2026
Oxurion maakt halfjaarresultaten 2026 bekend
Leuven, BELGIË – 30 september 2026 – 20:00 CET Oxurion NV(Euronext Brussel: OXUR) (de Vennootschap), een bedrijf met hoofdkantoor in Leuven, maakt vandaag haar financiële en zakelijke update bekend voor het half jaar dat eindigde op 30 juni 2026. Het halfjaarverslag is beschikbaar in de rubriek 'Investeerders' op de website van de Vennootschap en…
Actusnews Wire
30/09/2026
Oxurion Publishes First Half 2026 Results
Leuven, BELGIUM – September 30, 2026 – 08:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a company headquartered in Leuven, published today its financial and business update for the six-month period ending June 30, 2026. The half-year report is available in the 'Investors' section of the Company's website and can also be downloaded as a PDF…
Actusnews Wire
30/09/2026
Oxurion Receives Transparency Notifications from Atlas Special Opportunities II…
Leuven, BELGIUM – September 30, 2026 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received transparency notifications as follows: Oxurion received a transparency notification on September 29, 2026, from Atlas Special Opportunities…
Actusnews Wire
30/09/2026
Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II…
Leuven, BELGIË – 30 september 2026 – 18u00 CET Oxurion NV (Euronext Brussel: OXUR), een bedrijf met hoofdkantoor in Leuven, België, heeft vandaag aangekondigd dat het, in overeenstemming met de Belgische transparantiewetgeving1, de volgende transparantiekennisgevingen heeft ontvangen: Oxurion ontving een transparantiekennisgeving op 29 september…
Actusnews Wire
30/09/2026
Oxurion treedt in exclusieve onderhandelingen voor de overname van de…
Leuven, BELGIË – 30 september 2026 – 08u00 CET – Oxurion NV (Euronext Brussel: OXUR), een biofarmaceutische vennootschap gevestigd in Leuven, kondigt vandaag aan dat zij exclusieve onderhandelingen is gestart voor de overname van de operationele activiteiten en activa van Eclevar, een Franse CRO gespecialiseerd in de medische hulpmiddelensector…
Actusnews Wire
30/09/2026
Oxurion enters into exclusive negotiations to acquire the business and assets of…
Leuven, BELGIUM – September 30, 2026 – 08:00 AM CET - Oxurion NV (Euronext Brussels: OXUR), a company headquartered in Leuven, today announced that it has entered into exclusive negotiations to acquire the business and operating assets of Eclevar, a French CRO focused on the medical device industry. A strategic entry into the MedTech CRO market…
Actusnews Wire
30/09/2026
THX PHARMA REPORTS ITS FINANCIAL RESULTS FOR THE FIRST HALF OF 2026
Lyon, France – September 29, 2026 – 6:00 p.m. CEST – THX Pharma (formerly Theranexus), an innovative clinical-stage biopharmaceutical company focused on the treatment of rare neurological diseases, today announces its financial results for the six-month period ended June 30, 2026. Mathieu Charvériat, Chief Executive Officer of THX Pharma…
Actusnews Wire
29/09/2026
KLEA HOLDING : Still profitable in H1 2026, Klea Holding invests in its future…
First-half revenue of €8.6 million, despite the impact of regional conflicts; Positive EBITDA and net profit, demonstrating the Group's ability to adapt; More than €2 million in cash to support the development of new projects; Opening of Smart Health, launch of Klea Pharmaceuticals and ramp-up of Klea Health to support a return to profitable…
Actusnews Wire
28/09/2026
Altri Comunicati
